← All Invivyd, INC filings

Invivyd, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
IVVD
Invivyd, INC
SCHEDULE 13D/A: Adimab Reduces Invivyd Stake to 7.3%
Adimab, LLC has reported a decrease in its beneficial ownership of Invivyd, Inc. common stock to 7.3% following recent open market sales.
NASDAQ
IVVD
Invivyd, INC
SCHEDULE: Adimab Reduces Invivyd Stake to 8.8% After Share Sale
Adimab, LLC has reduced its beneficial ownership in Invivyd, Inc. to 8.8% after selling over 1.2 million shares in open market transactions.
NASDAQ
IVVD
Invivyd, INC
SCHEDULE: Mithril Capital's Stake in INVIVYD Dips to 4.8% Due to Dilution
Mithril Capital Management's beneficial ownership in INVIVYD, INC. decreased to 4.8% due to dilution from the issuer's recent share sales.
NASDAQ
IVVD
Invivyd, INC
SCHEDULE: Polaris Group's Stake in INVIVYD Dips to 3.0% Post-Dilution
Polaris Partners and affiliated entities report a decrease in their aggregate beneficial ownership of INVIVYD, INC. common stock to 3.0% following the issuer's recent share sales.
NASDAQ
IVVD
Invivyd, INC
SCHEDULE 13D/A: M28 Capital Exits Invivyd Stake Below 5%
M28 Capital Management LP and Marc Elia have filed an exit amendment to their Schedule 13D for Invivyd, Inc., indicating their beneficial ownership has fallen below 5% due to an increase in outstanding shares.